FI941053A0 - A mutated growth factor receptor useful as a drug and its use in the treatment of cancer - Google Patents

A mutated growth factor receptor useful as a drug and its use in the treatment of cancer

Info

Publication number
FI941053A0
FI941053A0 FI941053A FI941053A FI941053A0 FI 941053 A0 FI941053 A0 FI 941053A0 FI 941053 A FI941053 A FI 941053A FI 941053 A FI941053 A FI 941053A FI 941053 A0 FI941053 A0 FI 941053A0
Authority
FI
Finland
Prior art keywords
cancer
drug
treatment
growth factor
factor receptor
Prior art date
Application number
FI941053A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI941053A (en
Inventor
Norbert Redemann
Axel Ullrich
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of FI941053A0 publication Critical patent/FI941053A0/en
Publication of FI941053A publication Critical patent/FI941053A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI941053A 1991-09-05 1994-03-04 Mutant plant factor receptor useful as a drug and its use in the treatment of cancer FI941053A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19914129533 DE4129533A1 (en) 1991-09-05 1991-09-05 MUTTED GROWTH FACTOR RECEPTOR AS A MEDICINAL PRODUCT AND ITS USE FOR TREATING CANCER
PCT/EP1992/002058 WO1993005148A1 (en) 1991-09-05 1992-09-07 Mutated growth factor receptor as medicament and its use for treating cancer

Publications (2)

Publication Number Publication Date
FI941053A0 true FI941053A0 (en) 1994-03-04
FI941053A FI941053A (en) 1994-04-08

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941053A FI941053A (en) 1991-09-05 1994-03-04 Mutant plant factor receptor useful as a drug and its use in the treatment of cancer

Country Status (12)

Country Link
EP (1) EP0667899A1 (en)
JP (1) JPH07502884A (en)
CN (1) CN1071586A (en)
AU (1) AU669857B2 (en)
CA (1) CA2117073A1 (en)
DE (1) DE4129533A1 (en)
FI (1) FI941053A (en)
MX (1) MX9205084A (en)
NO (1) NO940778L (en)
NZ (1) NZ244239A (en)
PT (1) PT100844A (en)
WO (1) WO1993005148A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
CN104480200B (en) 2004-03-31 2017-12-29 综合医院公司 Determine method of the cancer to EGF-R ELISA magnetic target therapy reactivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
CA2055441C (en) * 1989-05-19 2003-01-07 Robert M. Hudziak Her2 extracellular domain
JP2975679B2 (en) * 1989-09-08 1999-11-10 ザ・ジョーンズ・ホプキンス・ユニバーシティ Structural change of EGF receptor gene in human glioma

Also Published As

Publication number Publication date
DE4129533A1 (en) 1993-03-11
AU2518592A (en) 1993-04-05
CN1071586A (en) 1993-05-05
MX9205084A (en) 1993-05-01
NO940778D0 (en) 1994-03-04
FI941053A (en) 1994-04-08
EP0667899A1 (en) 1995-08-23
NZ244239A (en) 1995-07-26
JPH07502884A (en) 1995-03-30
NO940778L (en) 1994-05-04
WO1993005148A1 (en) 1993-03-18
AU669857B2 (en) 1996-06-27
CA2117073A1 (en) 1993-03-18
PT100844A (en) 1994-05-31

Similar Documents

Publication Publication Date Title
DE69233491D1 (en) Pharmaceutical composition containing S-nitrosolipoproteins and their use
EG19187A (en) Quinazoline derivatives and their use as fungicide.
ATA901392A (en) HEPATITIS-C DIAGNOSIS AND VACCINE
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
FI944600A (en) Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy
DE69223266D1 (en) Peptide derivatives and their use
IT8768027A0 (en) DERIVATIVES OF 1 PIPERAZINIL PYRIMIDINE THEIR PREPARATION AND USE IN THERAPY AND COSMETICS
DE69230654D1 (en) Commiphora-Mukul extracts and their therapeutic use
GB9022368D0 (en) Materials useful in human and veterinary medicine
DE68910113T2 (en) GROWTH INHIBITANT AND ITS USE.
DE3879811D1 (en) PHARMACEUTICAL COMPOSITION AND THEIR USE.
IL99612A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
GB9103075D0 (en) Trinitrobenzene derivatives and their therapeutic use
FI940775A0 (en) process for the preparation of alpha-phenylisoserine derivatives and their use
FI941053A0 (en) A mutated growth factor receptor useful as a drug and its use in the treatment of cancer
FI973185A0 (en) Use of melatonin in the treatment of patients with drug dependence
DE69210474T2 (en) Medical-surgical hygiene articles and materials
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
DE59108548D1 (en) Implantable devices and materials
ZA924038B (en) New oxazole derivatives and their preparation and use
AU1745092A (en) Thiazolidine derivatives and their use in therapy
DE69121210D1 (en) THERAPEUTIC USE OF THE FIBROBLAST GROWTH FACTOR
DE69100923D1 (en) Pharmaceutical and / or cosmetic preparation.

Legal Events

Date Code Title Description
FD Application lapsed